Metis Global Partners LLC lessened its position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 30.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,947 shares of the company's stock after selling 838 shares during the period. Metis Global Partners LLC's holdings in Molina Healthcare were worth $567,000 at the end of the most recent reporting period.
Other hedge funds have also bought and sold shares of the company. True Wealth Design LLC grew its holdings in Molina Healthcare by 2,500.0% in the third quarter. True Wealth Design LLC now owns 104 shares of the company's stock worth $36,000 after purchasing an additional 100 shares during the period. Versant Capital Management Inc grew its holdings in Molina Healthcare by 83.1% in the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after purchasing an additional 74 shares during the period. Wingate Wealth Advisors Inc. acquired a new stake in Molina Healthcare in the fourth quarter worth $52,000. Financial Perspectives Inc acquired a new stake in Molina Healthcare in the fourth quarter worth $59,000. Finally, Capital Performance Advisors LLP acquired a new stake in Molina Healthcare in the third quarter worth $62,000. Institutional investors own 98.50% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the stock. Stephens restated an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Mizuho reduced their price target on shares of Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Barclays reduced their price objective on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a report on Friday, February 7th. UBS Group reduced their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a report on Friday, February 7th. Finally, StockNews.com cut shares of Molina Healthcare from a "strong-buy" rating to a "buy" rating in a report on Saturday, February 8th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $355.69.
Get Our Latest Analysis on MOH
Molina Healthcare Stock Up 1.0 %
Shares of MOH traded up $3.28 during trading hours on Friday, reaching $327.11. 1,060,986 shares of the stock traded hands, compared to its average volume of 773,847. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a fifty day simple moving average of $295.28 and a 200 day simple moving average of $311.91. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $423.92. The company has a market cap of $18.15 billion, a price-to-earnings ratio of 16.01, a PEG ratio of 1.06 and a beta of 0.56.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. On average, equities analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Insiders Place Their Bets
In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.10% of the company's stock.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
See Also

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.